Kala Bio Inc (KALA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KALA | AZN | AMGN | GILD | BMY |
| Company | Kala Bio Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.1750 | 204.75 | 345.45 | 139.24 | 59.12 |
| High | 0.1798 | 204.75 | 347.32 | 140.24 | 59.63 |
| Low | 0.1646 | 203.30 | 343.57 | 138.85 | 58.77 |
| Latest | 0.1693 | 204.12 | 347.64 | 140.38 | 59.36 |
| Change | -0.0009 | +0.63 | -0.30 | +0.67 | -1.74 |
| % Change | -0.53% | +0.31% | -0.09% | +0.48% | -2.85% |
| Volume | 713,086 | 112,936 | 284,534 | 257,134 | 585,439 |
| 20-Day Average Volume | 19,065,537 | 1,769,008 | 2,555,736 | 5,910,593 | 13,220,065 |
| Previous Close | 0.1702 | 203.49 | 347.94 | 139.71 | 59.60 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.2319 | 191.89 | 357.11 | 141.05 | 59.28 |
| 20-Day Raw Stochastic | 8.23% | 95.95% | 5.11% | 38.06% | 52.29% |
| 20-Day Relative Strength | 31.75 | 60.37 | 41.80 | 47.96 | 51.35 |
| Weighted Alpha | -73.06 | +52.89 | +20.73 | +34.23 | +24.13 |
| Today's Opinion | 100% Sell | 88% Buy | 24% Buy | 40% Buy | 100% Buy |
| Previous Opinion | 100% Sell | 88% Buy | 40% Buy | 40% Buy | 100% Buy |
| Last Month's Opinion | 100% Sell | 88% Buy | 88% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.11% since 03/27/26 | +8.19% since 03/27/26 | -0.95% since 03/27/26 | +4.12% since 03/27/26 | +1.59% since 03/27/26 |
| Low | 0.1455 on 04/02/26 | 192.61 on 03/30/26 | 343.57 on 04/06/26 | 133.89 on 03/30/26 | 58.83 on 04/06/26 |
| High | 0.1980 on 04/01/26 | 204.75 on 04/06/26 | 357.00 on 04/01/26 | 141.49 on 04/01/26 | 62.22 on 04/01/26 |
| 1-Month | |||||
| %Chg | -36.89% since 03/06/26 | +4.96% since 03/06/26 | -6.52% since 03/06/26 | -2.88% since 03/06/26 | -1.36% since 03/06/26 |
| Low | 0.1455 on 04/02/26 | 182.39 on 03/24/26 | 343.57 on 04/06/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 0.5100 on 03/11/26 | 204.75 on 04/06/26 | 380.14 on 03/11/26 | 149.38 on 03/10/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | -73.35% since 01/06/26 | +7.33% since 01/06/26 | +4.62% since 01/06/26 | +15.18% since 01/06/26 | +9.28% since 01/06/26 |
| Low | 0.1455 on 04/02/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.33 on 01/09/26 | 53.54 on 01/21/26 |
| High | 0.7100 on 01/16/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -88.45% since 10/06/25 | +19.22% since 10/06/25 | +17.45% since 10/06/25 | +23.07% since 10/06/25 | +31.75% since 10/06/25 |
| Low | 0.1455 on 04/02/26 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 112.82 on 10/07/25 | 42.52 on 10/29/25 |
| High | 1.9100 on 12/01/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 155,108 | 315,594,272 | 187,563,328 | 173,411,136 | 121,687,400 |
| Shares Outstanding, K | 911,330 | 1,550,908 | 539,068 | 1,241,222 | 2,041,735 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -38,510,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -7,560,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | -1.98 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.07 on 11/19/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/13/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.91 | 16.17 | 17.21 | 10.04 |